@MDTolgaAksu @DrRoderickTung @OCanoPerez @Dr_Santangeli @drrakeshg1 @Hapa_EP @Firaszahwe @aalahmadmd @andreanatalemd @DrJasonAndrade Took a bit of digging, but here’s the rationale for INR 1.6-2.6 and reduced dose rivaroxaban. cc @AkihikoNogami https://t.co/zdvYPmHcL0 https://t.co/z73EBcoxXf

RT @MDTolgaAksu: I liked that study from Japan although it is a restrospective study. They compared automatic annotation system (VISITAG mo…

@MDTolgaAksu @KrishKancharla @DrJasonAndrade @aalahmadmd @CarinaHardy4 @Hapa_EP @Firaszahwe @AlperDra @andreanatalemd @drrakeshg1 @DrMarwanRefaat Interestingly, this other paper from an Italian multicentre initiative (announced at the Europace session where I was heckled for suggesting PVI should routinely be possible with <20mins RF at 30W @drjohnm

@MDTolgaAksu @KrishKancharla @DrJasonAndrade @aalahmadmd @CarinaHardy4 @Hapa_EP @Firaszahwe @AlperDra @andreanatalemd @drrakeshg1 The RF duration isn’t stated in this paper but their earlier work shows that they assumed a min of 20s would be required at each site (defined by these stability settings), leading to these data: https://t.co/YtBkPwZQMu